A new HIV-prevention injection, lenacapavir, is being rolled out in parts of Africa.
The drug, taken only twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, making it functionally similar to a potent vaccine.. Click on the Read Original at the top to read Full news if you’re reading from Phoenix
South Africa, Eswatini, and Zambia are starting administration of lenacapavir today, offering new hope in the fight against HIV across the continent.
𝗙𝗼𝗹𝗹𝗼𝘄 𝗢𝘂𝗿 𝗪𝗵𝗮𝘁𝘀𝗔𝗽𝗽 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗧𝗼 𝗚𝗲𝘁 𝗟𝗮𝘁𝗲𝘀𝘁 𝗡𝗲𝘄𝘀 𝗔𝘀 𝗜𝘁'𝘀 𝗗𝗿𝗼𝗽!
